Plato Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,941
Closed -$15.9K – 504
2026
Q1
$15.9K Hold
2,941
– – ﹤0.01% 466
2025
Q4
$20.5K Hold
2,941
– – ﹤0.01% 457
2025
Q3
$18.8K Hold
2,941
– – ﹤0.01% 461
2025
Q2
$19.5K Hold
2,941
– – ﹤0.01% 464
2025
Q1
$19.3K Buy
+2,941
New +$21.1K ﹤0.01% 478
2024
Q4
– Sell
-90
Closed -$735 – 589
2024
Q3
$735 Buy
+90
New +$593 ﹤0.01% 543

Other funds holding BHC

Plato Investment Management's BHC Position: Q2 2026 in Review

Plato Investment Management sold out of Bausch Health (BHC) in Q2 2026, closing a stake of 2,941 shares — an estimated $15.9K sold.

Plato Investment Management first reported a position in BHC in Q3 2024 and held it in 6 quarters. The position peaked at $20.5K in Q4 2025. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Plato Investment Management reported no remaining Bausch Health position as of Q2 2026 after selling out during the quarter.
  • Plato Investment Management sold 2,941 Bausch Health shares in Q2 2026, an estimated $15.9K.
  • Plato Investment Management first reported a position in Bausch Health in Q3 2024 and held it in 6 quarters.
  • Plato Investment Management's Bausch Health position peaked at $20.5K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.